Home/Filings/4/0001628280-24-011494
4//SEC Filing

Warren Eric 4

Accession 0001628280-24-011494

CIK 0001434868other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 4:35 PM ET

Size

20.1 KB

Accession

0001628280-24-011494

Insider Transaction Report

Form 4
Period: 2024-03-14
Warren Eric
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2024-03-14+100,000168,318 total
  • Award

    Stock Option (right to buy)

    2024-03-14+150,000150,000 total
    Exercise: $2.05Exp: 2034-03-14Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2024.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001916048

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:35 PM ET
Size
20.1 KB